This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Generally gynaecomastia is a self limited benign condition (1).

  • reassurance and periodic follow-up are recommended in patients without an underlying pathology during appropriate work-up
  • if a specific cause of gynecomastia can be identified, it should be addressed e.g. -
    • offending medications should be withdrawn (1)
      • a reduction in tenderness softening of the glandular tissue will be evident within 1 month of discontinuation of the drug but in long standing cases (more than 1 year) due to the presence of fibrosis, substantial regression (spontaneously or with medical therapy) is unlikely (2)
    • underlying disorders should be treated, especially if onset of gynaecomastia is recent. eg, hyperthyroidism (1)

Treatment should be initiated in patients with persistent gynaecomastia or if it is associated with pain or psychological distress (1). Available treatment options include:

  • pharmacological
    • is beneficial when started early before development of fibrosis
    • treatment options include:
      • estrogen receptor modifiers - tamoxifen or raloxifene
      • dihydrotestosterone
      • danazol
      • clomiphene
      • aromatase inhibitors - testolactone and anastrozole (1)
      • a UK guidance (4) regarding hormonal treated has stated:
        • the patient must be informed that this treatment is off-licence
        • it is most effective for recent onset gynaecomastia, i.e. before gynaecomastia becomes fibrotic, and alleviates mastalgia, not always regression of the mass.
          • Tamoxifen 10mg PO OD: 3-9 months
          • Anastrozole 1mg PO OD: 3 months.
  • surgical
    • aims of surgery includes surgery include removing abnormal breast tissue, restoring the normal male breast contour, and reducing pain (3)
    • surgical techniques used include:
      • subcutaneous mastectomy with or without associated liposuction
      • liposuction - if enlargement is purely due to excess fatty tissue (without substantial glandular hypertrophy)
    • the complications of surgery include haematoma, infection, scarring, sensory changes, breast asymmetry and a poor cosmetic result (3).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.